# Middlesex Water Co: financial statements, quarterly

MSEX · Nasdaq · CIK 66004 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/msex.md) · [Financials](/companies/msex/financials.md) · [Filings](/companies/msex/filings.md) · [Insiders](/companies/msex/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/msex/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [38.6](/filings/0001174947-25-000318.md) | [40.5](/filings/0001174947-25-000318.md) | [49.1](/filings/0001174947-25-000318.md) | [55.1](/filings/0001628280-25-047821.md) | [47.1](/filings/0001174947-25-000318.md) | [44.3](/filings/0001628280-26-028887.md) | [49.3](/filings/0001628280-26-051038.md) | [54.1](/filings/0001628280-26-068210.md) | [47.0 d](/filings/0001628280-26-009777.md) | [48.7](/filings/0001628280-26-028887.md) | [56.4](/filings/0001628280-26-051038.md) | [60.2](/filings/0001628280-26-068210.md) |
| Operating income | $m | [8.2](/filings/0001174947-25-000318.md) | [9.9](/filings/0001174947-25-000677.md) | [15.3](/filings/0001174947-25-001119.md) | [17.5](/filings/0001628280-25-047821.md) | [10.5](/filings/0001174947-25-000318.md) | [11.6](/filings/0001628280-26-028887.md) | [13.9](/filings/0001628280-26-051038.md) | [17.7](/filings/0001628280-26-068210.md) | [11.2 d](/filings/0001628280-26-009777.md) | [13.1](/filings/0001628280-26-028887.md) | [18.2](/filings/0001628280-26-051038.md) | [22.3](/filings/0001628280-26-068210.md) |
| Interest expense | $m | [3.8 d](/filings/0001174947-24-000281.md) | [3.3](/filings/0001174947-24-000713.md) | [4.0](/filings/0001174947-24-000934.md) | [3.4](/filings/0001174947-24-001201.md) | [3.3 d](/filings/0001628280-26-009777.md) | [2.7](/filings/0001628280-26-028887.md) | [3.6](/filings/0001628280-26-051038.md) | [4.2](/filings/0001628280-26-068210.md) | [3.8 d](/filings/0001628280-26-009777.md) | [3.2](/filings/0001628280-26-028887.md) | [4.0](/filings/0001628280-26-051038.md) | [4.2](/filings/0001628280-26-068210.md) |
| Income tax | $m | [(0.1) d](/filings/0001628280-26-009777.md) | [1.3](/filings/0001174947-25-000677.md) | [3.4](/filings/0001174947-25-001119.md) | [1.7](/filings/0001628280-25-047821.md) | [0.5 d](/filings/0001628280-26-009777.md) | [1.2](/filings/0001628280-26-028887.md) | [1.4](/filings/0001628280-26-051038.md) | [1.4](/filings/0001628280-26-068210.md) | [0.8 d](/filings/0001628280-26-009777.md) | [1.3](/filings/0001628280-26-028887.md) | [1.8](/filings/0001628280-26-051038.md) | [2.4](/filings/0001628280-26-068210.md) |
| Net income | $m | [5.8](/filings/0001174947-25-000318.md) | [10.7](/filings/0001628280-25-047821.md) | [10.5](/filings/0001628280-25-047821.md) | [14.3](/filings/0001628280-25-047821.md) | [8.8](/filings/0001174947-25-000318.md) | [9.5](/filings/0001628280-26-068210.md) | [10.8](/filings/0001628280-26-068210.md) | [14.0](/filings/0001628280-26-068210.md) | [8.6 d](/filings/0001628280-26-009777.md) | [10.6](/filings/0001628280-26-068210.md) | [14.8](/filings/0001628280-26-068210.md) | [18.0](/filings/0001628280-26-068210.md) |
| Diluted EPS | $ per share | [0.32](/filings/0001174947-25-000318.md) | [0.59](/filings/0001174947-25-000677.md) | [0.59](/filings/0001174947-25-001119.md) | [0.80](/filings/0001628280-25-047821.md) | [0.49](/filings/0001174947-25-000318.md) | [0.53](/filings/0001628280-26-028887.md) | [0.60](/filings/0001628280-26-051038.md) | [0.77](/filings/0001628280-26-068210.md) | not reported | [0.57](/filings/0001628280-26-028887.md) | [0.79](/filings/0001628280-26-051038.md) | [0.95](/filings/0001628280-26-068210.md) |
| Basic EPS | $ per share | [0.32](/filings/0001174947-25-000318.md) | [0.60](/filings/0001174947-25-000677.md) | [0.59](/filings/0001174947-25-001119.md) | [0.80](/filings/0001628280-25-047821.md) | [0.49](/filings/0001174947-25-000318.md) | [0.53](/filings/0001628280-26-028887.md) | [0.60](/filings/0001628280-26-051038.md) | [0.77](/filings/0001628280-26-068210.md) | not reported | [0.57](/filings/0001628280-26-028887.md) | [0.79](/filings/0001628280-26-051038.md) | [0.95](/filings/0001628280-26-068210.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | period not labelled (2025-05-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [2.9](/filings/0001174947-24-000713.md) | [8.0](/filings/0001174947-24-000934.md) | [6.3](/filings/0001174947-24-001201.md) | [4.2](/filings/0001628280-26-009777.md) | not reported | not reported | [2.6](/filings/0001174947-25-001119.md) | [3.4](/filings/0001628280-25-047821.md) | [2.8](/filings/0001628280-26-068210.md) | [2.0](/filings/0001628280-26-028887.md) | [1.8](/filings/0001628280-26-051038.md) | [1.7](/filings/0001628280-26-068210.md) |
| Current assets | $m | [111](/filings/0001174947-24-000713.md) | [121](/filings/0001174947-24-000934.md) | [52.1](/filings/0001174947-24-001201.md) | [43.0](/filings/0001628280-26-009777.md) | [46.5](/filings/0001174947-25-000677.md) | not reported | [49.5](/filings/0001174947-25-001119.md) | [49.6](/filings/0001628280-25-047821.md) | [41.8](/filings/0001628280-26-068210.md) | [46.8](/filings/0001628280-26-028887.md) | [52.0](/filings/0001628280-26-051038.md) | [55.3](/filings/0001628280-26-068210.md) |
| Total assets | $m | [1,250](/filings/0001174947-24-000713.md) | [1,275](/filings/0001174947-24-000934.md) | [1,230](/filings/0001174947-24-001201.md) | [1,255](/filings/0001628280-26-009777.md) | [1,279](/filings/0001174947-25-000677.md) | not reported | [1,316](/filings/0001174947-25-001119.md) | [1,342](/filings/0001628280-25-047821.md) | [1,366](/filings/0001628280-26-068210.md) | [1,386](/filings/0001628280-26-028887.md) | [1,423](/filings/0001628280-26-051038.md) | [1,458](/filings/0001628280-26-068210.md) |
| Current liabilities | $m | [117](/filings/0001174947-24-000713.md) | [135](/filings/0001174947-24-000934.md) | [79.9](/filings/0001174947-24-001201.md) | [82.9](/filings/0001628280-26-009777.md) | [101](/filings/0001174947-25-000677.md) | not reported | [121](/filings/0001174947-25-001119.md) | [118](/filings/0001628280-25-047821.md) | [93.8](/filings/0001628280-26-068210.md) | [120](/filings/0001628280-26-028887.md) | [105](/filings/0001628280-26-051038.md) | [109](/filings/0001628280-26-068210.md) |
| Long-term debt | $m | [357](/filings/0001174947-24-000713.md) | [356](/filings/0001174947-24-000934.md) | [352](/filings/0001174947-24-001201.md) | [353](/filings/0001628280-26-009777.md) | [351](/filings/0001174947-25-000677.md) | [260](/filings/0001174947-25-001119.md) | [351](/filings/0001174947-25-001119.md) | [350](/filings/0001628280-25-047821.md) | [379](/filings/0001628280-26-068210.md) | [372](/filings/0001628280-26-028887.md) | [396](/filings/0001628280-26-051038.md) | [392](/filings/0001628280-26-068210.md) |
| Current portion of debt | $m | [364](/filings/0001174947-24-000713.md) | [363](/filings/0001174947-24-000934.md) | [359](/filings/0001174947-24-001201.md) | [7.7](/filings/0001628280-26-009777.md) | [358](/filings/0001174947-25-000677.md) | not reported | [358](/filings/0001174947-25-001119.md) | [7.6](/filings/0001628280-25-047821.md) | [7.9](/filings/0001628280-26-068210.md) | [7.7](/filings/0001628280-26-028887.md) | [7.7](/filings/0001628280-26-051038.md) | [7.4](/filings/0001628280-26-068210.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [428](/filings/0001628280-25-047821.md) | [433](/filings/0001628280-25-047821.md) | [442](/filings/0001628280-25-047821.md) | [445](/filings/0001628280-26-068210.md) | [449](/filings/0001628280-26-068210.md) | not reported | [458](/filings/0001628280-26-068210.md) | [483](/filings/0001628280-26-068210.md) | [494](/filings/0001628280-26-068210.md) | [501](/filings/0001628280-26-068210.md) | [521](/filings/0001628280-26-068210.md) | [548](/filings/0001628280-26-068210.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [12.8 d](/filings/0001628280-26-009777.md) | [6.7](/filings/0001174947-25-000677.md) | [11.2 d](/filings/0001174947-25-001119.md) | [19.5 d](/filings/0001628280-25-047821.md) | [21.4 d](/filings/0001628280-26-009777.md) | [13.8](/filings/0001628280-26-028887.md) | [18.3 d](/filings/0001628280-26-051038.md) | [12.0 d](/filings/0001628280-26-068210.md) | [18.5 d](/filings/0001628280-26-009777.md) | [11.7](/filings/0001628280-26-028887.md) | [16.4 d](/filings/0001628280-26-051038.md) | [22.9 d](/filings/0001628280-26-068210.md) |
| Capital expenditure | $m | [17.1 d](/filings/0001174947-25-000318.md) | [14.4](/filings/0001174947-24-000713.md) | [14.3 d](/filings/0001174947-24-000934.md) | [20.7 d](/filings/0001174947-24-001201.md) | [25.1 d](/filings/0001174947-25-000318.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [5.8 d](/filings/0001628280-26-009777.md) | [5.7](/filings/0001174947-25-000677.md) | [5.8 d](/filings/0001174947-25-001119.md) | [5.8 d](/filings/0001628280-25-047821.md) | [6.1 d](/filings/0001628280-26-009777.md) | [6.1](/filings/0001628280-26-028887.md) | [6.1 d](/filings/0001628280-26-051038.md) | [6.1 d](/filings/0001628280-26-068210.md) | [6.6 d](/filings/0001628280-26-009777.md) | [6.7](/filings/0001628280-26-028887.md) | [6.7 d](/filings/0001628280-26-051038.md) | [6.8 d](/filings/0001628280-26-068210.md) |
| Share repurchases | $m | [0.0 d](/filings/0001174947-25-000318.md) | [0.9](/filings/0001174947-25-000677.md) | [0.5 d](/filings/0001174947-25-001119.md) | [0.0 d](/filings/0001174947-24-001201.md) | [0.1 d](/filings/0001174947-25-000318.md) | [0.2](/filings/0001174947-25-000677.md) | [0.2 d](/filings/0001174947-25-001119.md) | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [17.8](/filings/0001174947-24-000713.md) | [17.8](/filings/0001174947-24-000934.md) | [17.9](/filings/0001174947-24-001201.md) | [17.9](/filings/0001174947-25-000677.md) | [17.9](/filings/0001174947-25-001119.md) | [18.0](/filings/0001628280-25-047821.md) | [18.0](/filings/0001628280-26-028887.md) | [18.0](/filings/0001628280-26-051038.md) | [18.2](/filings/0001628280-26-068210.md) | [18.6](/filings/0001628280-26-028887.md) | [18.7](/filings/0001628280-26-051038.md) | [19.0](/filings/0001628280-26-068210.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 19,129,679 at 2026-10-28, from the cover of the [10-Q filed 2026-10-29](/filings/0001628280-26-068210.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 16:49 ET. No prices; not investment advice.